Pharma Journalist -

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and systemic targeted radiation therapy of certain hard-to-treat…
Read More...

Telix announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of The University of Queensland (UQ), to develop a radiolabelled molecule targeting an…
Read More...

The PPD clinical research business of Thermo Fisher Scientific Inc., the world leader in serving science, announced plans to invest $59 million to significantly expand its laboratory…
Read More...

PTC Therapeutics, Inc. announced that it has entered into a strategic financing collaboration with funds managed by Blackstone to support its mission to reach a steady-state of…
Read More...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced that the European Medicines Agency (EMA) has…
Read More...

2seventy bio, Inc. and JW Therapeutics announced a strategic alliance to establish a translational and clinical cell therapy development platform designed to more rapidly explore T…
Read More...

SAE Media Group reports: Mitchell de Long, Vice President, Chemistry from Aerie Pharmaceuticals and Naj Sharif, Vice President, Ophthalmology Innovation Center from Santen Inc USA…
Read More...

Seres Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for investigational oral microbiome…
Read More...

Global biotechnology leader CSL announced the company has entered into a Strategic Option and License Agreement with Arizona-based Translational Sciences for their enhanced thrombus…
Read More...

WuXi Biologics announced it has successfully launched its drug substance GMP manufacturing facility (named MFG8) located in Shijiazhuang, Hebei Province, China. MFG8 is the 11th…
Read More...